{"id":"sumatriptan-and-naproxen-sodium","safety":{"commonSideEffects":[{"rate":null,"effect":"Chest pain or tightness"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Paresthesia"},{"rate":null,"effect":"Gastrointestinal upset"},{"rate":null,"effect":"Flushing"}]},"_chembl":null,"_dailymed":{"setId":"3f2ec27e-0e96-4028-a1fa-114e6d501464","title":"SUMATRIPTAN AND NAPROXEN SODIUM TABLET, FILM COATED [NORTHSTAR RXLLC]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Sumatriptan is a selective serotonin receptor agonist that causes vasoconstriction of cranial blood vessels and inhibits neuropeptide release, addressing the vascular and neurogenic components of migraine. Naproxen sodium is a nonsteroidal anti-inflammatory drug (NSAID) that blocks COX-1 and COX-2 enzymes, reducing prostaglandin synthesis and providing complementary pain relief and anti-inflammatory effects. The combination targets migraine through multiple mechanisms for enhanced efficacy.","oneSentence":"Sumatriptan activates serotonin 5-HT1B/1D receptors to relieve migraine pain, while naproxen sodium inhibits cyclooxygenase enzymes to reduce inflammation and provide additional analgesic effect.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:38:18.708Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute migraine with or without aura"}]},"trialDetails":[{"nctId":"NCT07103694","phase":"","title":"i-NEED: NEw migrainE Drugs Database","status":"RECRUITING","sponsor":"IRCCS San Raffaele Roma","startDate":"2022-03-24","conditions":"Episodic Migraine, Chronic Migraine, Medication Overuse Headache","enrollment":2641},{"nctId":"NCT06868953","phase":"","title":"Use of the Combination of Sumatriptan and Naproxen in the Acute Treatment of Migraine: Real World Evidence Study","status":"NOT_YET_RECRUITING","sponsor":"IRCCS San Raffaele Roma","startDate":"2025-04-10","conditions":"Migraine","enrollment":300},{"nctId":"NCT05854992","phase":"","title":"Treatments of Migraine with Triptans in Individuals with Elevated Cardiovascular Risk and in Pregnant Women","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2022-07-05","conditions":"Migraine, Cardiovascular Diseases, Pregnancy","enrollment":68419},{"nctId":"NCT04948164","phase":"PHASE3","title":"Study of Sumatriptan Naproxen Sodium Succinate Tablets for the Treatment of Acute Migraine Attacks","status":"UNKNOWN","sponsor":"Peking University Third Hospital","startDate":"2018-08-01","conditions":"Migraine in Adults","enrollment":240},{"nctId":"NCT01053507","phase":"PHASE4","title":"Treximet for Prevention of Post Traumatic Headache Associated With Cognitive Dysfunction","status":"TERMINATED","sponsor":"Cady, Roger, M.D.","startDate":"2010-05","conditions":"Post-Traumatic Headache","enrollment":23},{"nctId":"NCT01071317","phase":"PHASE4","title":"Trial of Comprehensive Migraine Intervention","status":"COMPLETED","sponsor":"Montefiore Medical Center","startDate":"2010-02","conditions":"Migraine","enrollment":50},{"nctId":"NCT02643719","phase":"NA","title":"Migraine Treatment in ED","status":"WITHDRAWN","sponsor":"NYU Langone Health","startDate":"2015-12","conditions":"Migraine","enrollment":""},{"nctId":"NCT00449787","phase":"PHASE4","title":"Comparing Naproxen to Sumatriptan for Emergency Headache Patients","status":"COMPLETED","sponsor":"Montefiore Medical Center","startDate":"2007-03","conditions":"Migraine, Tension-type Headache, Primary Headache Disorder","enrollment":401},{"nctId":"NCT01086358","phase":"PHASE4","title":"Does Treximet Improve Productivity and Patient Satisfaction Due to Sustained Response and Consistency of Response?","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2009-09","conditions":"Workplace Migraine Treatment","enrollment":60},{"nctId":"NCT00385008","phase":"PHASE3","title":"TREXIMA and RELPAX Gastric Scintigraphy Inside and Outside a Migraine","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-09-13","conditions":"Migraine Disorders","enrollment":20},{"nctId":"NCT00875784","phase":"PHASE1","title":"An Open-label, Randomized, 3-period Crossover Study to Evaluate Sumatriptan Pharmacokinetics for a TREXIMA™ (Sumatriptan Succinate / Naproxen Sodium) Tablet Followed by IMITREX® (Sumatriptan Succinate)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-05-06","conditions":"Migraine Disorders","enrollment":30},{"nctId":"NCT00989625","phase":"PHASE1","title":"A Pharmacokinetic Study to Evaluate TREXIMET in Adolescents With Migraine and Healthy Subjects Administered at Three Doses.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-11-04","conditions":"Migraine Disorders","enrollment":50},{"nctId":"NCT01332500","phase":"","title":"Treximet ™ Pharmacy Budget Impact Model Database Validation Study","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-07","conditions":"Migraine Disorders","enrollment":61737},{"nctId":"NCT00488514","phase":"PHASE3","title":"Long-Term Safety of Treximet (Sumatriptan/Naproxen Sodium) for Migraine in Adolescents","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-07-13","conditions":"Migraine Disorders","enrollment":656},{"nctId":"NCT00383162","phase":"PHASE3","title":"A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 1 of 2)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-11","conditions":"Migraine Disorders","enrollment":173},{"nctId":"NCT00382993","phase":"PHASE3","title":"A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-12","conditions":"Migraine Disorders","enrollment":169},{"nctId":"NCT00329355","phase":"PHASE3","title":"Menstrual Migraine Treatment With TREXIMET (Formerly Known as TREXIMA)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-05","conditions":"Migraine, Migraine Disorders","enrollment":351},{"nctId":"NCT00843024","phase":"PHASE3","title":"Migraine Study in Adolescent Patients","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-12","conditions":"Migraine Disorders","enrollment":589},{"nctId":"NCT00387881","phase":"PHASE3","title":"TREXIMET (Formerly Known as TREXIMA) for the Acute Treatment of Probable Migraine (ICHD-II 1.6.1)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-09","conditions":"Migraine, Without Aura","enrollment":679},{"nctId":"NCT00792636","phase":"PHASE4","title":"A Study to Determine the Effect of Sumatriptan and Naproxen Sodium Combination Tablet, Sumatriptan Tablet, and Naproxen Sodium Tablet on Blood Pressure When Treating Migraine Headaches That Occur During a 6-month Period","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-11","conditions":"Migraine Disorders","enrollment":407},{"nctId":"NCT00240617","phase":"PHASE3","title":"Study Of Treximet, Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-10","conditions":"Migraine Disorders","enrollment":623},{"nctId":"NCT00329459","phase":"PHASE3","title":"Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as TREXIMA, for Menstrual Migraine in Women With Dysmenorrhea","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-05","conditions":"Migraine Disorders","enrollment":320},{"nctId":"NCT01138150","phase":"PHASE4","title":"Ictal and Interictal Inflammatory Markers in Migraine","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2009-09","conditions":"Migraine","enrollment":36},{"nctId":"NCT01016678","phase":"PHASE2, PHASE3","title":"Treximet Early Intervention Adolescent Migraine","status":"COMPLETED","sponsor":"Premiere Research Institute","startDate":"2010-03","conditions":"Migraine","enrollment":104},{"nctId":"NCT00240630","phase":"PHASE3","title":"Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-10","conditions":"Migraine Disorders, Migraine","enrollment":646},{"nctId":"NCT01059604","phase":"","title":"Sumatriptan and Naratriptan Pregnancy Registry","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2001-12","conditions":"Migraine Disorders","enrollment":868},{"nctId":"NCT01329562","phase":"PHASE4","title":"CGRP, Estrogen, Cortisol, VIP, α-Amylase, PGE2, PGI2 and ß-Endorphin Levels in Menstrual Migraine Before and After Treximet","status":"COMPLETED","sponsor":"Cady, Roger, M.D.","startDate":"2011-05","conditions":"Menstrual Migraine","enrollment":41},{"nctId":"NCT01916395","phase":"","title":"Comparison of Treximet & Imitrex as They Affect the Levels of Inflammatory Markers When the Patient is Actively Having a Migraine Headache","status":"COMPLETED","sponsor":"Gary E. Ruoff, M.D.","startDate":"2009-12","conditions":"Migraine","enrollment":30},{"nctId":"NCT01090050","phase":"PHASE4","title":"Treximet in the Treatment of Chronic Migraine","status":"COMPLETED","sponsor":"Cady, Roger, M.D.","startDate":"2010-09","conditions":"Chronic Migraine","enrollment":56},{"nctId":"NCT01300546","phase":"PHASE4","title":"Treximet Trademark (TM) in the Prevention and Modification of Disease Progression in Migraine","status":"COMPLETED","sponsor":"Cady, Roger, M.D.","startDate":"2010-12","conditions":"Migraine","enrollment":40},{"nctId":"NCT01381523","phase":"","title":"A Combination Product of Sumatriptan and Naproxen Sodium Versus Single-entity Oral Triptans: An Analysis of Real World Data","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-11","conditions":"Migraine Disorders","enrollment":1},{"nctId":"NCT01112553","phase":"","title":"Treximet Migraine Brain Imaging Research Study","status":"TERMINATED","sponsor":"Mclean Hospital","startDate":"2010-04","conditions":"Acute Migraine","enrollment":2},{"nctId":"NCT01381497","phase":"","title":"Impact of Migraine on Work Productivity in Patients Treated With a Combination Product Containing Sumatriptan and Naproxen Sodium or Triptan Monotherapy","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-03","conditions":"Migraine Disorders","enrollment":1},{"nctId":"NCT01450995","phase":"PHASE4","title":"Migraine Treatment Satisfaction With Treximet Versus Concomitant 2 Aleve and Imitrex","status":"COMPLETED","sponsor":"Stephen H. Landy, M.D.","startDate":"2009-12","conditions":"Migraine","enrollment":50},{"nctId":"NCT00893737","phase":"PHASE4","title":"\"Completeness of Response\" Following Treatment With Treximet™ for Migraine","status":"COMPLETED","sponsor":"Cady, Roger, M.D.","startDate":"2009-06","conditions":"Migraine","enrollment":147},{"nctId":"NCT00573170","phase":"PHASE3","title":"TREXIMET® Versus Butalbital-containing Combination Medications for the Acute Treatment of Migraine in Adults","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-02","conditions":"Migraine Disorders, Migraine, Acute","enrollment":375},{"nctId":"NCT00837044","phase":"NA","title":"Treximet in Acute Migraine Headache: Assessing Cognitive Function","status":"UNKNOWN","sponsor":"Neurological Research Center","startDate":"2009-02","conditions":"Migraine Headache, Cognitive Impairment","enrollment":30},{"nctId":"NCT00442221","phase":"PHASE3","title":"The Safety Of Combo Formulation In The Treatment Of Multiple Episodes Of Acute Migraine Over 12 Months","status":"COMPLETED","sponsor":"POZEN","startDate":"2004-05","conditions":"Migraine Headaches","enrollment":500},{"nctId":"NCT00434083","phase":"PHASE3","title":"To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migrane Headaches","status":"COMPLETED","sponsor":"POZEN","startDate":"2004-07","conditions":"Migraine Headaches","enrollment":1200},{"nctId":"NCT00433732","phase":"PHASE3","title":"To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migraine Headaches","status":"COMPLETED","sponsor":"POZEN","startDate":"2004-08","conditions":"Migraine Headaches","enrollment":1400}],"_emaApprovals":[],"_faersSignals":[{"count":5,"reaction":"SEROTONIN SYNDROME"},{"count":4,"reaction":"DRUG INEFFECTIVE FOR UNAPPROVED INDICATION"},{"count":3,"reaction":"DRUG INEFFECTIVE"},{"count":2,"reaction":"APPENDICITIS"},{"count":2,"reaction":"DRUG INTERACTION"},{"count":2,"reaction":"INJECTION SITE PAIN"},{"count":2,"reaction":"OFF LABEL USE"},{"count":1,"reaction":"ABDOMINAL PAIN"},{"count":1,"reaction":"ACCIDENTAL EXPOSURE TO PRODUCT"},{"count":1,"reaction":"BLOOD GLUCOSE INCREASED"}],"_approvalHistory":[],"publicationCount":70,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Sumatriptan and Naproxen sodium","genericName":"Sumatriptan and Naproxen sodium","companyName":"POZEN","companyId":"pozen","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Sumatriptan activates serotonin 5-HT1B/1D receptors to relieve migraine pain, while naproxen sodium inhibits cyclooxygenase enzymes to reduce inflammation and provide additional analgesic effect. Used for Acute migraine with or without aura.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}